Page results
-
This page is for patients who have been referred by their GP to a gynaecology specialist because their symptoms need further tests.
-
This page tells you about having a PICC (Peripherally Inserted Central Catheter) line insertion with the Vascular Access team.
-
A UCLH/UCL clinical trial of a personalised therapy for blood cancer has been expanded, meaning new groups of patients with a wider range of blood cancers are now receiving the treatment.
-
This booklet tells you about having a Vortex® Port-a-cath Insertion (implantable port) with the Interventional Radiology team.
-
A large trial at UCLH and UCL will investigate whether a drug currently in use to treat respiratory conditions can slow the progress of Parkinson’s disease.
-
Exhibition co-curated by Healthcare Arts Collective and UCLH Arts and Heritage 25th August - 20th October 2021, UCH Street Gallery, 235 Euston Road
-
This page tells you about having a PICC (Peripherally Inserted Central Catheter) line insertion with the Interventional Radiology team.
-
This page tells you about having a Non-Tunnelled CVC Line Insertion (Vascath). This page is for those patients who have been referred to Interventional Radiology.
-
A drug commonly used to treat cystic fibrosis improved outcomes for patients with severe COVID-19 pneumonia and could be used to treat other respiratory infections, according to clinical trial results from researchers at UCLH, UCL and the Francis Crick Institute.
-
Breakthroughs in Alzheimer’s disease are exciting and invigorating dementia research, and we will need to be ready to deliver new treatments as they come through, say Professor Nick Fox and Dr Catherine Mummery.
File results
-
FOI2017186 Cyber security and cyber attacks
-
FOI2017182 Cancer patients treated with certain drugs
-
FOI2017178 Closure to admissions of the maternity unit
-
Charity Matters magazine - Winter 2020
-
FOI2017125 Restraint of patients
-
FOI2017126 Staff infected by blood-borne virus by patients
-
FOI2017129 Water hygiene
-
FOI2017123 Information on the price paid, total expenditure and total volume held of Cyanide antidotes, Levothyroxine and Primidone medications
-
FOI2017133 IT strategy/bussiness plan
-
FOI2017141 Provision of aids to patients having had total hip replacements